Literature DB >> 74604

Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.

D W Fraser, I Wachsmuth, C Bopp, J C Feeley, T F Tsai.   

Abstract

Erythromycin and rifampicin (rifampin) were able to prevent death of guineapigs given intraperitoneal injections of the agent causing legionnaires' disease. Penicillin, chloramphenicol, tetracycline, and gentamicin showed no significant effect. On the basis of clinical experience and experimental observations, erythromycin is recommended for patients suspected to have legionnaires' disease. Combined therapy with erythromycin and rifampicin may be justified in patients with confirmed legionnaires' disease who are not responding to erythromycin alone or as part of a controlled antibiotic trial among suspected cases during an outbreak of legionnaires' disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 74604     DOI: 10.1016/s0140-6736(78)90611-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Response of Legionella pneumophila to beta-lactam antibiotics.

Authors:  S Weisholtz; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

2.  Direct activation of human monocyte-derived macrophages by a bacterial glycoprotein extract inhibits the intracellular multiplication of virulent Legionella pneumophila serogroup 1.

Authors:  P Rajagopalan; E Dournon; J L Vildé; J J Pocidalo
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

3.  Legionnaires' disease in a renal transplant recipient.

Authors:  H J Canos; A R Ronald; J R Jeffery
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

4.  A sporadic case of Legionnaires' disease.

Authors:  A R Rachlis
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

5.  Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.

Authors:  A W Pasculle; J N Dowling; F N Frola; D A McDevitt; M A Levi
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 6.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

7.  Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

Review 8.  Legionellosis.

Authors:  J A Blackmon; F W Chandler; W B Cherry; A C England; J C Feeley; M D Hicklin; R M McKinney; H W Wilkinson
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

9.  A fatal case of Legionnaires' disease originating in Scotland.

Authors:  A W Lees; W F Tyrrell; J F Boyd
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

10.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.